2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Intestinal Neoplasms
2
Colonic Neoplasms
2
Polyps
1
Inflammatory Bowel Diseases
1
Colonic Polyps
1
Interventions
Irinotecan
8
Bevacizumab
8
Fluorouracil
7
Leucovorin
6
Oxaliplatin
5
Capecitabine
4
Drug Therapy
3
Cetuximab
3
5,10-methylenetetrahydrofolic acid
3
Radiotherapy
2
Levoleucovorin
2
Folfox protocol
2
Colonoscopy
2
Bisacodyl
2
Aspirin
2
Artesunate
2
trametinib
1
spartalizumab
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
nazartinib
1
napabucasin
1
lutetium Lu 177 dotatate
1
guadecitabine
1
encorafenib
1
copper dotatate CU-64
1
canakinumab
1
camrelizumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Intestinal Neoplasms
×
Bisacodyl
×
Clear all
NCT05032794
2022-12-07
CriLiP
Parc Taulà Hospital Universitari
Phase NA
Completed
553 enrolled
NCT01887158
2014-06-17
PEGOP
Ospedale Santa Maria delle Croci
Phase 4
Completed
116 enrolled